iTeos Therapeutics, Inc. (ITOS) Net Income by Year
iTeos Therapeutics, Inc. reported a net loss of $134.4M in fiscal year 2024. This represents a decrease of 19.3% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters iTeos Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ITOS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ITOS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More iTeos Therapeutics, Inc. financials
Frequently Asked Questions
What was iTeos Therapeutics, Inc.'s net income in fiscal year 2024?
iTeos Therapeutics, Inc. reported a net loss of $134.4M in fiscal year 2024.
How fast is iTeos Therapeutics, Inc.'s net income growing?
iTeos Therapeutics, Inc. (ITOS) net income fell by 19.3% year over year, from -$112.6M to -$134.4M in fiscal year 2024.
How has iTeos Therapeutics, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, iTeos Therapeutics, Inc. (ITOS) net income went from -$22.5M in fiscal year 2019 to -$134.4M in fiscal year 2024.
What was iTeos Therapeutics, Inc.'s net income in the most recent quarter?
iTeos Therapeutics, Inc. (ITOS) reported -$78.7M in net income in Q2 2025. This represents a decrease of 1004.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what iTeos Therapeutics, Inc. (ITOS) reported on that line in every period on record.